https://www.ncbi.nlm.nih.gov/Structure/pdb/4YTC
Tyrosine-protein kinase JAK2N~3~-phenyl-1-[6-(phenylamino)pyrimidin-4-yl]-1H-1,2,4-triazole-3,5-diamine
discoveryvxdecernotinibpotentselective
https://pubmed.ncbi.nlm.nih.gov/9774334/
Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is an essential physiological process in development, yet also plays a major role in...
crystal structureangiogenesis inhibitorboundfgf
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egfr-tyrosine-kinase-inhibitor
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
tyrosine kinase inhibitordefinitionegfrncidictionary
https://pubmed.ncbi.nlm.nih.gov/18183025/
Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity are...
quantitative analysiskinase inhibitorselectivity
https://www.ncbi.nlm.nih.gov/Structure/pdb/5TT7
Tyrosine-protein kinase SYK2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-5-one
discoverytakorallyavailableinhibitor
https://www.news-medical.net/life-sciences/What-is-a-Kinase-Inhibitor.aspx
A protein kinase inhibitor is a type of enzyme inhibitor that can block the action of protein kinases. Protein kinases add a phosphate group to a protein in a...
what iskinase inhibitor
https://pubmed.ncbi.nlm.nih.gov/16699172/
Controlling aberrant kinase-mediated cellular signaling is a major strategy in cancer therapy; successful protein kinase inhibitors such as Tarceva and Gleevec...
protein kinase astructural analysismutantsrho
https://www.ncbi.nlm.nih.gov/Structure/pdb/3MJW
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma...
kinasegammainhibitor
https://pubmed.ncbi.nlm.nih.gov/38641704/
CSF1R is a receptor tyrosine kinase responsible for the growth/survival/polarization of macrophages and overexpressed in some AML patients. We hypothesized...
kinase inhibitornovelmultipotentactivity
https://www.ncbi.nlm.nih.gov/Structure/pdb/4AW5
EPHRIN TYPE-B RECEPTOR 4(3Z)-5-[(1-ethylpiperidin-4-yl)amino]-3-[(5-methoxy-1H-benzimidazol-2-yl)(phenyl)methylidene]-1,3-dihydro-2H-indol-2-one
complexkinasedomainoxindole